[Post hip fracture care]

R Tandjung; T Rosemann

doi:10.1024/1661-8157/a000614

[Post hip fracture care]

Praxis (Bern 1994). 2011 Jul 27;100(15):917-21. doi: 10.1024/1661-8157/a000614.

[Article in German]

Authors

R Tandjung¹, T Rosemann

Affiliation

¹ Institut für Hausarztmedizin und Versorgungsforschung der Uni Zürich, Universitätsspital Zürich. [email protected]

PMID: 21792807
DOI: 10.1024/1661-8157/a000614

Abstract

Hip fractures are common and associated with high mortality and morbidity. Patients with hip fractures have a high risk of refractures. Osteoporosis is the underlying cause. A therapy with bisphosphonates is indicated without the need of further diagnostic testing with a bone marrow densitometry.

Publication types

English Abstract
Review

MeSH terms

Absorptiometry, Photon
Aged
Bone Density Conservation Agents / adverse effects
Bone Density Conservation Agents / therapeutic use*
Calcium / therapeutic use
Diphosphonates / adverse effects
Diphosphonates / therapeutic use*
Female
Femoral Neck Fractures / diagnosis
Femoral Neck Fractures / drug therapy*
Humans
Male
Middle Aged
Osteoporosis, Postmenopausal / diagnosis
Osteoporosis, Postmenopausal / drug therapy*
Osteoporotic Fractures / diagnosis
Osteoporotic Fractures / drug therapy*
Secondary Prevention
Vitamin D / therapeutic use

Substances

Bone Density Conservation Agents
Diphosphonates
Vitamin D
Calcium